Cargando…
Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy?
Pseudomonas aeruginosa is an important Gram‐negative pathogen with intrinsic resistance to many clinically used antibiotics. It is particularly troublesome in nosocomial infections, immunocompromised patients, and individuals with cystic fibrosis. Antimicrobial resistance (AMR) is a huge threat to g...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804370/ https://www.ncbi.nlm.nih.gov/pubmed/35837865 http://dx.doi.org/10.1111/1462-2920.16136 |
_version_ | 1784862092591890432 |
---|---|
author | Lyon, Rhiannon Jones, Rebekah A. Shropshire, Holly Aberdeen, Isabel Scanlan, David J. Millard, Andrew Chen, Yin |
author_facet | Lyon, Rhiannon Jones, Rebekah A. Shropshire, Holly Aberdeen, Isabel Scanlan, David J. Millard, Andrew Chen, Yin |
author_sort | Lyon, Rhiannon |
collection | PubMed |
description | Pseudomonas aeruginosa is an important Gram‐negative pathogen with intrinsic resistance to many clinically used antibiotics. It is particularly troublesome in nosocomial infections, immunocompromised patients, and individuals with cystic fibrosis. Antimicrobial resistance (AMR) is a huge threat to global health, with a predicted 10 million people dying from resistant infections by 2050. A promising therapy for combatting AMR infections is phage therapy. However, more research is required to investigate mechanisms that may influence the efficacy of phage therapy. An important overlooked aspect is the impact of membrane lipid remodelling on phage binding ability. P. aeruginosa undergoes changes in membrane lipids when it encounters phosphorus stress, an environmental perturbation that is likely to occur during infection. Lipid changes include the substitution of glycerophospholipids with surrogate glycolipids and the over‐production of ornithine‐containing aminolipids. Given that membrane lipids are known to influence the structure and function of membrane proteins, we propose that changes in the composition of membrane lipids during infection may alter phage binding and subsequent phage infection dynamics. Consideration of such effects needs to be urgently prioritised in order to develop the most effective phage therapy strategies for P. aeruginosa infections. |
format | Online Article Text |
id | pubmed-9804370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98043702023-01-03 Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy? Lyon, Rhiannon Jones, Rebekah A. Shropshire, Holly Aberdeen, Isabel Scanlan, David J. Millard, Andrew Chen, Yin Environ Microbiol Minireviews Pseudomonas aeruginosa is an important Gram‐negative pathogen with intrinsic resistance to many clinically used antibiotics. It is particularly troublesome in nosocomial infections, immunocompromised patients, and individuals with cystic fibrosis. Antimicrobial resistance (AMR) is a huge threat to global health, with a predicted 10 million people dying from resistant infections by 2050. A promising therapy for combatting AMR infections is phage therapy. However, more research is required to investigate mechanisms that may influence the efficacy of phage therapy. An important overlooked aspect is the impact of membrane lipid remodelling on phage binding ability. P. aeruginosa undergoes changes in membrane lipids when it encounters phosphorus stress, an environmental perturbation that is likely to occur during infection. Lipid changes include the substitution of glycerophospholipids with surrogate glycolipids and the over‐production of ornithine‐containing aminolipids. Given that membrane lipids are known to influence the structure and function of membrane proteins, we propose that changes in the composition of membrane lipids during infection may alter phage binding and subsequent phage infection dynamics. Consideration of such effects needs to be urgently prioritised in order to develop the most effective phage therapy strategies for P. aeruginosa infections. John Wiley & Sons, Inc. 2022-08-14 2022-10 /pmc/articles/PMC9804370/ /pubmed/35837865 http://dx.doi.org/10.1111/1462-2920.16136 Text en © 2022 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Minireviews Lyon, Rhiannon Jones, Rebekah A. Shropshire, Holly Aberdeen, Isabel Scanlan, David J. Millard, Andrew Chen, Yin Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy? |
title | Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy? |
title_full | Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy? |
title_fullStr | Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy? |
title_full_unstemmed | Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy? |
title_short | Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy? |
title_sort | membrane lipid renovation in pseudomonas aeruginosa ‐ implications for phage therapy? |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804370/ https://www.ncbi.nlm.nih.gov/pubmed/35837865 http://dx.doi.org/10.1111/1462-2920.16136 |
work_keys_str_mv | AT lyonrhiannon membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy AT jonesrebekaha membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy AT shropshireholly membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy AT aberdeenisabel membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy AT scanlandavidj membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy AT millardandrew membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy AT chenyin membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy |